Related Subjects:
|Acute Stroke Assessment (ROSIER&NIHSS)
|Atrial Fibrillation
|Atrial Myxoma
|Causes of Stroke
|Ischaemic Stroke
|Cancer and Stroke
|Cardioembolic stroke
|CT Basics for Stroke
|Endocarditis and Stroke
|Haemorrhagic Stroke
|Stroke Thrombolysis
|Hyperacute Stroke Care
π§ Introduction
Paradoxical embolism = passage of an embolus (usually thrombus from DVT) from the venous system β arterial system, bypassing the pulmonary filter.
This requires a right-to-left shunt (e.g. PFO, ASD, AVM) and can cause stroke, systemic emboli, or MI.
β‘ Clinical suspicion is essential, especially in young patients with cryptogenic stroke.
π Etiology
- π« Intracardiac shunts: PFO, ASD, VSD (Eisenmenger), complex congenital heart disease.
- π« Pulmonary AVMs: direct venous β arterial connection.
- β¬οΈ Raised right atrial pressure: pulmonary hypertension, Valsalva manoeuvres (cough, straining, lifting).
βοΈ Pathophysiology β βThe 3 Ingredientsβ
- π©Έ Source of embolus: classically DVT in legs/pelvis.
- β‘οΈ Right-to-left shunt: anatomical defect bypassing lungs.
- π Pressure gradient favouring shunt: transient β RA pressure vs LA (e.g. Valsalva).
πͺ Common Shunts
- πΉ PFO: in 25% of population; up to 50% in cryptogenic stroke. Often incidental but clinically important if DVT present. Closure β recurrence in select patients.
- πΉ ASD: usually LβR, but RβL possible if RA pressure β. Bubble study diagnostic.
- πΉ VSD: RβL only if Eisenmenger physiology develops (pulmonary HTN).
- πΉ Congenital cyanotic lesions: e.g. Tetralogy of Fallot, TGA.
- πΉ Pulmonary AVMs: allow emboli to bypass capillary filter; classically with HHT.
π©Ί Clinical Presentation
- β‘ Stroke/TIA: sudden focal deficit, multiple vascular territories possible.
- 𦡠Peripheral embolism: acute limb ischaemia (pain, pallor, pulseless).
- β€οΈ MI: rarely, coronary occlusion.
- π Multisystem emboli: simultaneous infarcts in brain + limb + other organs.
- π¨ Precipitated by Valsalva: coughing, sneezing, heavy lifting.
π§ͺ Investigations
- π©Έ Bloods: FBC, coagulation, thrombophilia screen if young/cryptogenic.
- π ECG: AF (alternative cause); RBBB/RA strain (suggests ASD).
- πΌ Neuroimaging: CT/MRI β multiple embolic infarcts raise suspicion.
- π« CTPA: look for pulmonary AVM or PE.
- π« Echocardiography:
- TTE β chamber/valve assessment.
- TEE β better for small shunts, LAA thrombus, vegetations.
- Bubble study: agitated saline β bubbles in LA = shunt.
- π Transcranial Doppler with bubble study: detects microbubbles in cerebral vessels.
- 𦡠Doppler legs: exclude DVT.
β
Evidence For vs π« Against Paradoxical Embolism
- β
Multiple vascular territory infarcts.
- β
Concurrent DVT/PE.
- β
Positive bubble echo / RβL shunt proven.
- π« AF or large artery stenosis identified instead.
- π« Single-territory infarct, stereotyped recurrences.
βοΈ Management
- π Anticoagulation: DOACs/warfarin if DVT/PE present. Antiplatelets alone less protective.
- π©» Closure procedures: percutaneous closure of PFO/ASD in selected pts with recurrent cryptogenic stroke + proven shunt.
- π« AVM embolization: coil/plug closure by interventional radiology.
- π‘ Risk factor modification: stop smoking, treat HTN, DM, dyslipidaemia.
- π§ββοΈ Education: avoid excessive Valsalva, recognise DVT/stroke symptoms early.
π Prognosis
Recurrence risk is significant if shunt + DVT not addressed.
π Anticoagulation + closure in selected pts markedly improves outcomes.
π Without intervention, recurrent paradoxical emboli β disabling stroke or systemic ischaemia.
π References
- Alsheikh-Ali AA, Thaler DE, Kent DM. PFO in cryptogenic stroke. Stroke. 2009.
- Overell JR et al. Interatrial septal abnormalities and stroke: meta-analysis. Neurology. 2000.
- Mojadidi MK et al. Cryptogenic stroke & PFO. JACC. 2018.
- RodΓ©s-Cabau J et al. Device closure of PFO. JACC. 2009.
- Kasner SE et al. Rivaroxaban vs Aspirin in ESUS & PFO. Stroke. 2021.